Search

everythinglearnresearchcommunity

for

Search:↓

Long COVID causes lasting symptoms and needs ongoing care.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Minoxidil can improve hair growth in some patients with woolly hair due to LIPH variants, with varying responses and mild side effects.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Quarantine stress likely worsened hair loss in women, but video consultations helped manage their condition and reduce anxiety.

A patient developed a severe skin reaction and died after taking hydroxychloroquine for COVID-19.

Patients reduced searches for dermatology issues during COVID-19, indicating a need for better telehealth services.

The French COVID-19 lockdown caused delays in diagnosing new melanoma cases, making them more severe.

Public interest in skin issues changed during COVID-19, with more focus on dry skin, hair problems, and hand eczema.

Some drugs may help treat both COVID-19 and radiation injury.

Men on 5-alpha-reductase inhibitors might have worse COVID-19 outcomes.

Some recovered COVID-19 patients experience skin, hair, and nail issues, suggesting they need follow-up care.

The review found that COVID-19 can cause skin problems, including rashes and issues from wearing PPE, and suggests more research and protective measures for healthcare workers.

Gender-affirming care for youth remained essential during the COVID-19 pandemic, with telemedicine playing a key role.

One in four people still had symptoms like weight loss, hair loss, and fatigue 12-14 weeks after recovering from COVID-19.

During the COVID-19 pandemic in Turkey, the most common skin problem for both kids and adults was acne.

Teletrichoscopy is a promising method for diagnosing hair disorders remotely during the COVID-19 pandemic.

More children are showing signs of hair-pulling disorders during the COVID-19 pandemic due to stress and lack of social interaction.

AGA might indicate higher risk for severe COVID-19.

Long-lasting COVID-19 symptoms like fatigue and breathing difficulties can persist for over 60 days, requiring ongoing care.

Male hormones may make COVID-19 worse, while substances that block these hormones could lessen symptoms.

Long-term effects of COVID-19 can vary over time and are more likely in certain age and gender groups, while race, income, and education levels have little to no impact. Ongoing medical care is needed due to potential complications.

Psoriasis treatments don't raise severe COVID-19 risk, except for acitretin.

Many hospitalized children with COVID-19 had skin, mouth, or nail changes, with skin rashes being common.

Some people still have COVID-19 symptoms after 90 days, especially older patients and those with severe initial symptoms, but most return to normal.

Certain skin symptoms in COVID-19 patients may indicate a more severe illness.

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.